Swiss Biosimilars Update Embraces Foreign Comparators
Switzerland’s regulatory agency is open to accepting foreign comparator products for biosimilar applications. But bridging studies are likely to be required, its latest guideline suggests.
Switzerland’s regulatory agency is open to accepting foreign comparator products for biosimilar applications. But bridging studies are likely to be required, its latest guideline suggests.